The objective of this experiment was to determine if growth, carcass composition, and myofiber characteristics of lambs were affected by heterozygosity for a myostatin mutation (g+6723G>A) when offered differing allowances of feed administered with or without ractopamine. Heterozygote [MSTN A/G (n = 40)] and homozygote wildtype [MSTN G/G (n = 39)] castrate male lambs were individually fed ad libitum (HI; 1.8 × estimated ME m ) or a restricted allowance (LO; 1.1 × estimated ME m ) of a diet (191 g of CP/ kg of DM and 12 MJ of ME/kg of DM), supplemented with (0.4 mg/kg of BW) or without the β-adrenergic agonist ractopamine (RAC or NO RAC) for 47 d. The lambs were scanned by computed tomography at the beginning and completion of the feeding experiment to calculate composition of lean, fat, and bone in the carcass component of the body. The MSTN A/G HI intake lambs had significantly greater total daily carcass growth (P = 0.045) and loin eye depth (P = 0.022) and tended to have a greater daily growth of lean (P = 0.09) in the carcass, compared with MSTN G/G HI intake lambs. Conversely, MSTN A/G LO intake lambs tended to have less daily lean deposition (P = 0.09), significantly less total daily carcass growth (P = 0.045), and had a greater percentage of type IIX myofibers (P < 0.01) and total myofiber area (relative area) of type IIX myofibers (P = 0.013). The inclusion of RAC increased final BW (P = 0.03) and ADG (P = 0.02), percentage of type IIC (P < 0.001) and IIA (P = 0.012) myofibers, cross-sectional area of types I (P = 0.04) and IIAX (P = 0.04) fibers, and the relative area of type IIC (P = 0.003) and IIA (P = 0.01) myofibers in the LM. The experiment demonstrated that including RAC in the diet of lambs increased final BW and ADG, but not HCW, and increased proportion of type IIC and IIA myofibers and cross-sectional area of type I and IIAX myofibers. Our data suggest that RAC and the heterozygous myostatin mutation act together to increase growth of muscle on a high plane of nutrition. The experiment also demonstrated that poor nutritional background of lambs heterozygous for the myostatin mutation may negatively influence their growth rates and myofiber characteristics.
INTRODUCTION
The use of major genes that produce high-yielding and quality lamb meat is an important option in selective breeding programs for prime lamb production. The presence of the myostatin g+6723G>A mutation in sheep has been found to increase muscle and decrease fat in the carcass (Clop et al., 2006; Kijas et al., 2007; Johnson et al., 2009) . It has been reported elsewhere (Wegner et al., 2000) that the reduction in myostatin, as a consequence of gene mutation, leads to smaller muscle fibers. In addition, dietary administration of β-adrenergic agonists increases carcass lean and reduces fat, and is known to affect skeletal muscle fiber characteristics by increasing muscle fiber size (Beermann, 2002) . Because myostatin acts to regulate muscle mass through activin type II receptors (Lee and McPherron, 2001 ) and β-adrenergic agonists through cyclic adenosine monophosphate (cAMP; Mersmann, 1998) , we hypothesized that ractopamine (RAC) may differentially affect muscle growth and characteristics in the presence of the myostatin g+6723G>A mutation. Recent studies evaluating the effects of the myostatin g+6723G>A mutation have been carried out on animals that have been raised under grazing systems with no control or knowledge of the feed intake of the lambs (Kijas et al., 2007; Johnson et al., 2009; Masri et al., 2011) . The effect of nutrient supply on expression of muscle traits in sheep with the myostatin g+6723G>A mutation is unknown.
Hence, in this study, we tested the hypothesis that heterozygote lambs for the myostatin g+6723G>A mutation, offered a high dietary allowance and treated with the β-adrenergic agonist (RAC), would increase the accretion of muscle and alter myofiber characteristics. Computed tomography scanning was used to determine the growth of components (lean, fat, and bone) of the carcass equivalent in live sheep, and changes to myofiber characteristics were assessed in the LM after slaughter. The expectation is that information gained from this study will contribute to an understanding of how meat yield and quality can be improved without compromising nutritional and quality attributes of the meat for human consumption.
MATERIALS AND METHODS
Use and care of the animals in this experiment were approved by the University of New England's Animal Ethics Committee. The lambs were housed at the University of New England (Armidale, New South Wales, Australia; altitude 980 m) animal house facility in individual pens.
Animals, Diet, Experimental Design, and Slaughter
Eighty crossbred (progeny of Border Leicester cross Merino ewes mated to White Suffolk or Poll Dorset sires) 5-mo-old wether lambs with an initial BW of 40.1 ± 3.8 kg with or without the myostatin g+6723G>A mutation were selected for study. The sheep were genotyped to confirm the presence of 1 A myostatin allele [g+6723G>A myostatin mutation (heterozygote; MSTN A/G, n = 40)] or no A alleles [homozygote; wild types (MSTN G/G, n = 40)]. The lambs were offered a commercially manufactured pelleted feed (Ridley Stockfeeds, Tamworth, New South Wales, Australia). The feed pellets contained 89.8% DM, 12 MJ of ME/kg of DM, and 191 g of CP/kg of DM, 2% NaCl. Table 1 shows the ingredients of the pelleted ration. The lambs were fed once a day at 0900 h with ad libitum access to water. Lambs were accustomed to the diet over a 10-d period during which time they received declining amounts of oaten chaff while being gradually introduced to the manufactured pellets. During the feeding experiment, the lambs received the pellets for 47 d.
Lambs were offered 1 of 2 levels of feed availability: ad libitum (HI) or restricted (LO). The HI intake lambs consumed approximately 1,180 g of DM/d, and the LO intake lambs were offered 720 g of DM/d (approximately 1.8 and 1.1 × estimated ME requirement for maintenance per day, respectively), which remained constant during the 47-d feeding experiment with no adjustments for BW gain. One-half of each dietary group were offered feed supplemented with the β-adrenergic agonist RAC (Paylean 20, ractopamine hydrochloride, Elanco Animal Health, West Ryde, New South Wales, Australia) at 0.4 mg/kg of initial BW (Walker et al., 2006) or not treated with RAC (NO RAC). The RAC dose was not adjusted for BW gain throughout the duration of the experiment. The lambs were randomly assigned to feeding level according to genotype. Treatment groups were balanced for initial BW within a 2 × 2 × 2 factorial design (MSTN A/G vs. MSTN G/G; HI vs. LO; RAC or NO RAC) experiment with 10 animals per cell (n = 80). Immediately before beginning the feeding experiment, lamb BW was recorded after overnight fasting. Fasted BW was subsequently recorded on d 11, 18, 25, 39, 45 , and 47, of the 47-d feeding trial.
At the completion of the feeding experiment, the animals were transported 3 h to a commercial abattoir (Country Fresh, Wallangarra, Queensland, Australia) and held in lairage overnight. The lambs were slaughtered by electrical stunning and exsanguination. At the abattoir, HCW and total soft tissue depth 110 mm from the midline over the 12th rib (GR) were recorded.
The day after slaughter, when the carcasses were all less than 7°C, the entire LM was removed from the left side of each carcass, weighed and packed in individual plastic bags, and stored at 4°C for later sampling for myofiber classification.
Genotyping
The DNA was extracted from blood samples taken from each lamb and assayed for the myostatin g+6723G>A mutation at the SNP in the 3′ untranslated region of myostatin by PCR with primers described by Kijas et al. (2007) . Before beginning the experiment, whole blood samples were collected from each lamb from a jugular vein into 10-mL EDTA Vacutainer tubes. The tubes were immediately placed on ice and then stored at −20°C. The DNA was extracted from whole blood. By-product of bread wheat consisting of wheat pollard and bran.
X-Ray Computed Tomography of the Live Lambs
Estimates of the weight of lean, fat and bone in the carcass equivalent of the live animal were obtained using x-ray computed tomography (CT) analysis of the animals at the beginning and completion of the 47-d experimental feeding experiment. Lambs were scanned live and without sedation using a CT scanner, (Picker UltraZ 2000 CT scanner, Philips Medical Imaging Australia, Sydney, New South Wales, Australia) with a 457-mm diameter image as described by Haynes et al. (2010) . Feed was withheld the night before scanning, resulting in the lambs going approximately 16 h without feed. At scanning, the lambs were strapped on their backs into a semi-cylindrical cradle and foam pads were used to support the head and neck. The front legs were strapped to the chest and the hind legs restrained in clamps. Each animal had from 60 to 66 (number of scans depended on the size of the animal) serial 5-mm cross-sectional CT images taken at 15-mm intervals, starting at the 2nd cervical vertebra and moving through the torso to finish approximately halfway along the tibia.
The total lean (muscle and connective tissue), fat, bone, eye muscle depth (EMD), fat depth measured 45 mm from the midline of the 12th rib (C site), and GR from each lamb were calculated by removing the noncarcass components of each CT image as described by Haynes et al. (2010) . Skin was also included in the images, but all other soft tissues, namely heart, lungs, liver, kidney, and gut components, and their contents were excluded using the open-source software program, Osirix (Rosset et al., 2004; Haynes et al., 2010) . The software program Autocat was then used to compute the total weight of lean, fat, and bone and to predict total carcass weight (Thompson and Kinghorn, 1992) .
The average daily growth of lean, fat, and bone in the carcass for each animal was calculated as the difference between the initial and final body component weight (lean, fat, bone, and a total of each of these components) divided by the number of days between measurements. The change in growth of EMD, C site, and GR was calculated from the initial and final CT scans.
The CT data collected from these animals have been reported in an abstract describing the method used to predict CT BW and CT carcass weight (Haynes et al., 2010) . The relationship between the final predicted CT carcass weight and HCW had an r 2 of 0.96, and between CT carcass weight and HCW had an r 2 of 0.98 (Haynes et al., 2010) , with the difference in intercept between these 2 relationships attributable to skin and blood in the lambs at the time of scanning, which were not present after slaughter.
Myofiber Characterization
Samples of the LM collected as described above and were prepared for immunohistochemistry based on their myosin heavy chain staining characteristics (Picard et al., 1998; Greenwood et al., 2006a Greenwood et al., ,b, 2007 . Thirty hours postslaughter, samples of the LM were mounted onto labeled cork blocks using gum tragacanth (product No. 3001141483, Sigma-Aldrich, Castle Hill, New South Wales, Australia). Mounted samples were immersed in isopentane and cooled to approximately −190°C in liquid nitrogen before storage of the histological samples at −70°C.
Myofibers were prepared for immunochemistry by cutting serial cross sections from the mounted LM sample. Serial, 10-µm-thick cross sections were cut at −25°C using a cryostat microtome (ThermoShandon AS 620 Cryostat SME, Thermotrace Ltd., Noble Park, Victoria, Australia), placed in sequential order on individual slides, and allowed to dry at room temperature before storage at −20°C.
To determine myofiber characteristics, the samples were prepared for immunocytochemistry staining and classification based on 5 myofiber types (I, IIC, IIA, IIAX, and IIX), according to the myosin heavy chain staining characteristics using 3 antibodies (Picard et al., 1998; Greenwood et al., 2007 Greenwood et al., , 2009 ). The slides were removed from −20°C storage, thawed at room temperature, and then fixed with 100% acetone. After fixation, a circle was drawn around each tissue sample using a hydrophobic pen to create a well. Within the well, the muscle sections were recovered with 0.01 M of PBS (pH 7.2) and blocked with 10% nonimmune serum solution (Zymed Laboratories, South San Francisco, CA) for 10 min. The samples were incubated in a humid chamber with 50 µL of monoclonal antibody raised against type I major histocompatibility complex (clone WB-MHCs, Novocastra, Newcastle upon Tyne, UK; diluted 1:100 in PBS) plus rabbit anti-laminin, affinity-isolated antibody (Sigma Chemical Co., St. Louis, MO; diluted 1:500 in PBS), type II MHC (clone MY-32, Sigma Chemical Co.; diluted 1:1,200 in PBS), and types I, IIB, and IIX MHC (clone S5 8H2, Picard et al., 1998) ; diluted 1:1,000 in PBS) for 1 h at 37°C. Antibodies were detected using a broad-spectrum Labeled-[Strept]-Avidin-Biotin amplification system and the substrate chromagen, diaminobenzidine (Zymed Laboratories). The sections were then dehydrated and clarified with graded ethanols (70, 85, 95, and 100%) and xylenes, and mounted using a xylene-based mounting medium and glass coverslips.
The LM myofibers were classified based on positive, negative, or intermediate staining with each antibody as detailed in Greenwood et al. (2006b Greenwood et al. ( , 2007 Greenwood et al. ( , 2009 ). Myofibers were classified as types I (slow oxidative), IIC (intermediate or transitional between types I and IIA), IIA (fast oxidative-glycolytic), IIAX (intermediate or transitional between types IIA and IIX), or IIX (fast glycolytic). Myofiber types previously classified as types IIAB and IIB were classified as types IIAX and IIX, respectively, because of little or no expression of type IIB MHC in skeletal muscles of ruminants as detailed in Greenwood et al. (2007 Greenwood et al. ( , 2009 ). Fields of view were assessed using 10× and 20× objectives. The 10× objective was used to identify the location of fields within muscle sections. The 20× objective was then used to classify each myofiber according to antibody staining profiles. Classification was performed using images captured by the software program Axiovision (Carl Zeiss Pty Ltd., Göttingen, Germany).
Statistical Analyses
The effects of level of feed intake, myostatin genotype, RAC, and their interactions were analyzed as a GLM using R version 2.10.1 (R Foundation for Statistical Computing, Vienna, Austria, http://www.r-project. org). Data were adjusted for covariates (initial BW, initial scan weight, and HCW) depending on the logical connection between the trait and expected effect and level of significance. Only significant (P < 0.05) covariates were retained in the statistical models. Two animals were removed from the analyses. The first lamb was removed from the analyses of the feeding experiment (HI MSTN G/G) due to its low feed intake. The second was removed from the CT composition analysis (HI MSTN A/G) due to a read failure in the CT image files. Interactions for all fixed effects and covariates were tested, and significant effects at P < 0.05 are reported. Tendencies are reported when P-value is >0.05 to <0.10.
RESULTS

Nutritional Effects on Live and Carcass Traits
Effects of nutrition (HI or LO level of feed intake), inclusion or exclusion of RAC (RAC or NO RAC), and heterozygote (MSTN A/G) or homozygote (MSTN G/G) for the myostatin g+6723G>A mutation on growth and carcass traits of the lambs are presented in Table 2 . The LO lambs had reduced (P = 0.001) final BW, ADG, HCW, and GR in comparison with the HI lambs. The RAC lambs had increased final BW (P = 0.03) and ADG (P = 0.02). There was no effect (P > 0.10) of genotype on any growth or carcass traits.
RAC Increases ADG
The HI RAC lambs were associated with increase in BW gain over time (Figure 1) . These lambs had an increase (P = 0.006) in BW gain of 1.3 kg by d 25 of the experiment. Differences in BW gain remained at this level over the remainder of the feeding period.
CT Analysis: Daily Growth of Tissues
At both feed intake levels, fat gain was greater (P < 0.001) than lean gain. The LO lambs had less (P < 0.001) muscle, fat, bone, and total carcass deposition compared with the HI lambs (Table 3 ). Genotype and RAC had no influence (P ≥ 0.43) on any of the CT-derived carcass components; however, there were interactions between level of feed intake, genotype, and RAC as detailed below.
Interactions between the level of feed intake and myostatin genotype on average daily growth of body components were evident (Table 4) . The LO MSTN A/G lambs had significantly less total carcass growth (P = 0.045) than the LO MSTN G/G lambs, and a tendency for less total accretion of lean (P = 0.09). All the lambs had greater (P < 0.001) average daily fat deposition than muscle deposition irrespective of genotype, nutritional, or RAC treatment.
There were interactions between level of feed intake, inclusion, or exclusion of RAC and myostatin status for average accretion of carcass fat, bone, and lean. The HI MSTN A/G RAC lambs had reduced fat deposition (P = 0.014) compared with HI MSTN G/G RAC lambs (96.9 vs. 101.4 g/d, n = 10 and 9, respectively, SE = 3.3 g/d). By contrast, LO MSTN A/G RAC lambs had greater fat deposition (P = 0.014) compared with the Table 2 . Least squares means of the main effects on growth (final BW, ADG, and DMI) and carcass traits [HCW, dressing percentage, total soft tissue depth 110 mm from the midline over the 12th rib (GR), and intramuscular fat %] of wether lambs offered ad libitum or restricted feed intake (HI or LO, respectively), with or without the β-agonist ractopamine (RAC or NO RAC) and differing in myostatin status (MSTN A/G or MSTN G/G) 
CT Carcass Traits
Effects of genotype on carcass traits as affected by nutrition are presented in Table 5 . The HI MSTN A/G lambs had a 2.1-mm greater (P = 0.002) accretion of EMD than the equivalent HI MSTN G/G group. There were no interactions between genotype and feed intake for change in C site fat depth (P = 0.166) or GR tissue depth (P = 0.138). The GR tissue thickness and C site fat depth were greater (P < 0.001) in lambs eating the HI compared with the LO diet.
Myofiber Characteristics
Main Effects: Percentage of Myofibers. Ractopamine had the largest effect on the percentage of different myofibers within the LM (Table 6 ). Ractopamine reduced (P < 0.001) the percentage of type IIC and increased (P = 0.012) the percentage of type IIA myofibers. The level of feed intake and MSTN A/G genotype did not significantly (P ≥ 0.18) affect the percentages of myofiber types.
Cross-Sectional Area. Low intake resulted in significantly smaller (P ≤ 0.001) cross-sectional area (CSA) of type IIA, IIAX, and IIX and the average CSA, and tended (P = 0.07) to result in smaller CSA of type I myofibers. Ractopamine increased CSA of type I (P = 0.04) and type IIAX (P = 0.04) myofibers. Diet, RAC, or genotype had no other significant (P ≥ 0.24) effects on myofiber type CSA.
Relative Area of Myofiber Type (Percentage of Total Myofiber Area). The LO lambs had decreased (P = 0.04) relative area of type IIAX myofibers. The RAC lambs had reduced (P = 0.003) relative area of type IIC and increased (P = 0.010) relative area of type IIA myofibers. Ractopamine also tended (P = 0.084) to increase the relative area of type IIAX and decrease (P = 0.098) type IIX myofibers. Genotype did not have any significant effect on relative area of myofibers. Table 3 . Least squares means for the main effects on average daily accretion (g/d) for muscle (lean), fat, bone, and the total carcass of wether lambs offered ad libitum or restricted feed intake (HI or LO), with or without the β-agonist ractopamine (RAC or NO RAC) and differing in myostatin status (MSTN A/G Within the same row, mean values with different superscripts differ (P < 0.05) or tend to differ (P < 0.10, italics).
1
MSTN A/G = heterozygote for myostatin mutation (g+6723G>A); MSTN G/G = homozygote wildtype.
Interactions Between Level of Feed Intake and Myostatin Status
Percentage of Myofibers and CSA. Interactions between myostatin status and feed intake for myofiber characteristics are presented in Table 7 . The LO MSTN A/G lambs had a greater (P < 0.01) percentage of IIX myofibers and a tendency (P = 0.08) toward a reduced percentage of type IIA myofibers compared with the MSTN G/G lambs. In contrast, the HI MSTN A/G lambs had fewer (P < 0.01) type IIX myofibers than MSTN G/G lambs. Percentage of myofibers did not differ (P > 0.10) due to nutrition within the MSTN G/G lambs.
There were no interactions (P ≥ 0.17) between myostatin status and nutrition for CSA of LM myofibers.
Relative Area of Myofiber Types. The LO MSTN A/G lambs had increased (P = 0.013) relative area of type IIX myofibers and a tendency (P = 0.09) to decreased type IIAX myofibers. Conversely, the HI MSTN A/G lambs had a reduced (P = 0.013) relative area of type IIX myofibers, a tendency for increased (P = 0.09) relative area of type IIA, and a significant (P = 0.039) increase in IIAX myofibers compared with those on LO intake. No differences (P > 0.10) were due to nutrition in the relative area of myofiber types within the MSTN G/G lambs.
Interactions of Feed Intake and RAC
Percentage of Myofibers. The LO RAC lambs increased (P = 0.04) the percentage of type IIAX myofibers and tended to reduce (P = 0.07) the percentage of type IIC myofibers (Table 8 ). There were no other interactions (P ≥ 0.16) with RAC for the percentages of myofiber types.
CSA of Myofibers. The LO RAC lambs increased (P = 0.046) the CSA of type IIA myofibers and tended to increase (P = 0.05) CSA of types IIC, IIAX (P = 0.05), and IIX (P = 0.08) and the overall average CSA (P = 0.08) of myofibers. Ractopamine did not affect CSA in the HI intake lambs.
Relative Area of Myofiber Types. The LO NO RAC lambs had a decreased (P = 0.04) relative area of IIAX myofibers. The HI intake lambs not given RAC tended to have an increased (P = 0.09) relative area composed of IIC myofibers. There were no other interactions (P ≥ 0.16) with RAC for the relative areas of myofiber types.
DISCUSSION
The objective of this experiment was to evaluate if there was an improvement in growth of muscle mass for lambs heterozygote for the myostatin g+6723G>A mu- Table 6 . Least squares means of LM myofiber characteristics for wether lambs that were offered ad libitum or restricted feed intake (HI or LO), with or without the β-agonist ractopamine (RAC or NO RAC, respectively), and differing in myostatin status (MSTN A/G Within a row, mean values without a common superscript differ (P < 0.05) or tend to differ (P < 0.10, italics).
1 MSTN A/G = heterozygote for myostatin mutation (g+6723G>A); MSTN G/G = homozygote wildtype.
tation treated with RAC when fed a high dietary allowance. Myostatin and RAC are both known to increase muscle mass, but by 2 different mechanisms. Myostatin regulates muscle cell growth and proliferation through the activin type 2 cell receptors, which signals through the SMAD family, activating glycogen synthase kinase (GSK)-3β and inhibiting P13K/Akt (Yang et al., 2007; Matsakas and Patel, 2009 ). Mutations of the myostatin gene reduce myostatin activity and therefore increased skeletal muscle mass. On the other hand, RAC is a β-adrenergic agonist that binds to β-adrenergic agonist cell receptors to activate adenylate cyclase and cAMP (Mersmann, 1998) . Results reported here suggest that the combination of mechanisms on muscle mass is additive in lambs. Nutrient supply was used to provide a further contrast to alter potential muscle growth in this experiment. Greater nutrient supply allows for a larger muscling by increasing the rate of synthesis relative to degradation of myofibrillar and sarcoplasmic proteins. Therefore, in addition to a greater genetic potential for an increase in muscle accretion resulting from the myostatin g+6723G>A mutation and the inclusion of RAC in the lamb diets, we anticipated that different nutrient supply would contribute to further changes in muscle mass and myofiber characteristics. Double-muscled cattle breeds (such as the Piedmontese and Belgian Blue), known to be carriers of myostatin mutations (Kambadur et al., 1997; McPherron and Lee, 1997) , offered restricted energy intake mobilized energy reserves to a greater magnitude than nondouble-muscled cattle breeds (Fiems et al., 2007) . The mobilization of energy reserves has been attributed to these animals having a greater proportion of glycolytic (faster type II) muscle fiber types, which are known to have a reduced number of mitochondria that may reduce fat oxidation (Fiems et al., 2007) . The greater proportion of glycolytic muscle fibers could be attributed to the myostatin gene as it is known to affect the number, size, and contractile properties of muscle fiber characteristics in cattle (Wegner et al., 2000; Bünger et al., 2009) . In sheep, the Texel breed, known carriers of the myostatin g+6723G>A mutation (Clop et al., 2006) , are also reported to have a greater muscling and decreased fat content with a greater percentage of glycolytic muscle fibers (Bünger et al., 2009) . Therefore, it is expected that in the case of a restricted feed intake, lambs with a greater proportion of glycolytic myofibers would also have greater mobilization of fat.
As expected, nutritional restriction resulted in slower growth rates, which consequently reduced rates of gain of carcass lean, fat, and bone. Lambs with the myostatin g+6723G>A mutation grew slower than the wild type when nutritionally restricted. The LO intake affected the muscle fiber characteristics of the LM by increasing the percentage and relative area of type IIX myofibers, and in addition, a tendency to decrease the percentage of IIA myofibers. On the high plane of nutrition, heterozygote lambs had a decreased proportion of IIX and a tendency toward an increased proportion of type IIA myofibers. This suggests that the myofibers of LM of MSTN A/G lambs become more glycolytic when less feed is available. Picard et al. (2002) reported that type IIA and IIX myofibers show reciprocal changes, partic- ularly during the later stages of postnatal development.
Here we have shown that the nutritional background of lambs heterozygous at the g+6723G>A locus may influence their muscle biochemical phenotype. Earlier research has shown that selection of lambs using EBV for muscling increased type IIX myofibers with commensurate reduction in eating quality (Gardner et al., 2006 (Gardner et al., , 2007 Greenwood et al., 2006b) . Estimated breeding values are a broad selection tool for increasing genetic gain that is likely to involve the contributions of many genes of small effect (Hayes et al., 2010) . In this experiment, there was no application of selective pressure on the genetic background, but rather, the effects are of one copy of a single A allele in an otherwise unselected heterogenous genetic background.
Previous research on animals with the myostatin g+6723G>A mutation found that there was a difference in skeletal muscle phenotype, depending on the number of A alleles [V. H. Oddy, F. E. M. Haynes, P. J. Allingham (CSIRO, Livestock Industries, Brisbane, Australia), J. D. White (University of Melbourne, Melbourne, Australia), J. W. Kijas (CSIRO, Livestock Industries, Brisbane, Australia), and P. L. Greenwood, unpublished] . Two copies of the A allele resulted in an approximately 12% increase in carcass lean vs. a 9% increase for 1 copy of the A allele (as determined by CT scanning). These observations are similar to those reported by Johnson et al. (2009) , who also found an association between the number of A alleles and lean meat yield. Kijas et al. (2007) and Johnson et al. (2009) found that the A allele was associated with increased carcass muscle mass and decreased fat content. However, there is limited information on the effect of myofiber characteristics on lambs with 1 or 2 copies of the myostatin g+6723G>A mutation.
The inclusion of RAC was responsible for improving final BW by 2% and ADG by 12%. The divergence in BW gain was not apparent until the third week of treatment, with the inclusion of RAC resulting in greater BW for those animals offered the greater intake diet. In pigs, the ADG response to RAC is somewhat variable, occurring somewhere within a timeframe of approximately 6 d to 3 wk from initial treatment (Armstrong et al., 2004) . There was no evidence of change in carcass weight or dressing percentage, nor was there any observed effect on subcutaneous fat or intramuscular fat content. Further analysis on these animals has found that the inclusion of RAC in the diet of lambs reduced the digestibility of the feed and may, therefore, have increased retention of feed in the digestive track. This could explain why there was an increase in final BW and ADG, but no increase in HCW or dressing percentage (F. E. M. Haynes, V. H. Oddy, P. L. Greenwood, and M. B. McDonagh, unpublished data) . Similarly, Strydom et al. (2009) reported that RAC in cattle feedlot rations did increase ADG but had no effect on final BW. Gu et al. (1991) reported increased lean and reduced fatness after RAC administration over a range of pig genotypes. It is also apparent that pigs treated with RAC must be provided with greater amounts of dietary CP to facilitate greater growth and carcass size. Dunshea et al. (1998) reported that RAC reduced fatness in gilts given restricted access to feed with >14% CP in the diet. By contrast, in this experiment, CP content of the lamb diet was 19%, substantially in excess of their minimum requirement, suggesting protein supply was not limiting.
In those animals that were treated with RAC, but had restricted intake, the percentage and CSA of transitional myofibers (type IIC and IIAX) was altered such that the reduction in percentage of type IIC was matched by an increase in type IIAX. Strydom et al. (2009) reported that inclusion of RAC in cattle diets increased size and percentage ratio of fast glycolytic myofibers. In the present study, RAC stimulated the conversion of type IIC (a known transitional myofiber) to the more glycolytic type IIAX types, but type IIX myofibers did not increase.
In conclusion, the results show that heterozygote MSTN A/G lambs on a high nutritional allowance had a greater average daily growth rate than the homozygous normal lambs. Nutritional restriction adversely affected the heterozygote lambs such that restricted MSTN A/G lambs had decreased total average daily carcass growth compared with homozygous normal lambs. Nutritional restriction in the MSTN A/G lambs increased the percentage and relative area of type IIX and tended to reduce IIA myofiber types. As a consequence, a high plane of nutrition is required to benefit from the potential for improved growth in myostatin heterozygote (g+6723G>A) lambs and to prevent the transition of myofibers toward more glycolytic types, at least in the LM. The inclusion of RAC increased ADG and final BW while facilitating the transitions of type IIC to more glycolytic myofibers. Interactions between myostatin status, RAC treatment, and nutritional plane were evident and together provide methods to alter carcass composition in general (lean, fat, and bone) and thereby lean yield.
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